Cyient DLM Ltd
Q4 FY27 Earnings Call Analysis
Industrial Manufacturing
fundraise: No informationcapex: Yesrevenue: Category 2margin: Category 1orderbook: Yes
💰fundraise
Any current/future new fundraising through debt or equity?
- No specific mention of any new fundraising through debt or equity in the current quarter or near future.
- The company is currently net cash positive with strong balance sheet and has "dry powder" (available capacity) to raise working capital by another INR350-400 crores if needed.
- They have sufficient land, infrastructure, and buildings in place for expansion and can add equipment quickly without large lead times.
- The company is actively scouting for both organic and inorganic growth opportunities, including acquisitions, but no new deals/raises announced yet.
- IPO proceeds utilization stands at 93.2%, with working capital and capex planned based on business needs.
- Overall, the financial position is strong, and expansions are planned to be funded from internal accruals and available financial resources without immediate need for new fundraising.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Regular capex and maintenance ongoing at 1% to 2% of revenues.
- Ability to quickly execute additional capex for specific customer needs; equipment/line additions have 3-6 months lead time.
- Land, infrastructure, and building capacity already in place, enabling rapid scaling with new equipment.
- Utilization of IPO proceeds: 15.4% deployed towards capex as of December 2025, with more planned in coming quarters.
- Focus on investments in advanced manufacturing technologies (MES, automation, digitization) to improve efficiency and quality.
- Continued investment in B2S capabilities and technology stacks to scale design-led growth.
- Strategic inorganic growth pursued via acquisitions to expand geographies and capabilities; previously pursued but called off a $17.75 million M&A deal, with ongoing scouting.
- Expect balanced capital deployment between organic growth, technology investment, and potential acquisitions.
📊revenue
Future growth expectations in sales/revenue/volumes?
- FY '27 expected to see double-digit growth in build-to-spec (B2S) revenue, increasing from around 6-7% in FY '26 to over 10%.
- Strong order intake momentum with book-to-bill ratio >1.5 YTD, indicating robust revenue visibility.
- Q4 FY '26 anticipated to have positive year-on-year revenue growth, marking a turnaround from recent declines.
- FY '27 revenue growth expected to be substantial, driven by new sales team efforts, industry mix shift, and expansion into new geographies and segments (aerospace, industrial, medical, automotive).
- Build-to-spec programs beginning revenue realization in FY '26, with significant scaling and margin expansion expected from FY '27 onwards.
- Strong order book (~INR 2400 crores) with healthy margins, supporting 20-25% growth projection for FY '27.
- Continued investments in sales, technology, and operational excellence to support long-term growth and improved margins.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- FY '27 expected to show slight double-digit growth in revenue with good growth from FY '28 onwards, driven by B2S programs and improved industry mix.
- Margins anticipated to improve due to operating leverage, industry mix shift, and build-to-spec (B2S) ramp-up; margins to sustain around 10% range.
- Strong order book and diversified customer base providing robust revenue visibility and support for future growth.
- Operational efficiencies and scale benefits expected to drive further margin expansion and profitability.
- Investment in sales leadership and new technologies underpins confidence in sustained growth and margin expansion.
- Positive net cash position and balance sheet strength to support capacity expansion and strategic initiatives, including organic and inorganic growth.
- Earnings and PAT margins expected to improve as scale returns, with normalized EBITDA margin at 10.2% in latest quarter showing potential upside.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- As of Q3 FY '26, the order book stands strong at INR 23.5 billion (approximately INR 2,350 crores), reflecting a quarter-on-quarter increase of INR 583 million.
- This marks the third consecutive quarter of positive momentum in order intake.
- The orders booked carry healthy and structurally improved margin profiles compared to historical levels.
- The book-to-bill ratio stands at 1.56 on a year-to-date basis, indicating robust revenue visibility.
- New orders and strong repeat business contributed to a healthy quarterly order intake of INR 387 crores.
- The order book's margins are projected to be better than current margins, supporting double-digit profitability.
- Build-to-spec revenue is currently about 6-7% of total revenue and is expected to grow to double digits in FY '27, aiding margin expansion.
- The backlog supports positive growth visibility for Q4 and FY '27, with expectations of a 20-25% revenue growth in FY '27.
